SCHEMBL4155753

SCHEMBL4155753

NC(=O)c1cccc(-c2cncc(NCc3ccc(Cl)c(Cl)c3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.46
CLK1 P49759 1/20 0.46
FYN P06241 2/20 0.45
AURKA O14965 2/20 0.44
RPS6KB1 P23443 2/20 0.44
VNN1 O95497 2/20 0.44
DYRK1A Q13627 2/20 0.44
CLK4 Q9HAZ1 2/20 0.44
CD38 P28907 1/20 0.44
BRAF P15056 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
FFAR1 O14842 1/20 0.43
CCNT1 O60563 2/20 0.41
CDK9 P50750 2/20 0.41
CCND1 P24385 1/20 0.41
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
CDK7 P50613 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4140370 0.91 CLK1 (0.48) S1PR1CLK1FYNAURKARPS6KB1
SCHEMBL4153724 0.89 MAP4K4 (0.49) CLK1FYNAURKARPS6KB1VNN1
SCHEMBL4155314 0.88 VNN1 (0.55) CLK1FYNAURKARPS6KB1VNN1
SCHEMBL4155055 0.85 FYN (0.53) CLK1FYNAURKARPS6KB1VNN1
SCHEMBL4156327 0.85 CLK1 (0.50) CLK1FYNAURKARPS6KB1VNN1
SCHEMBL4143243 0.84 FYN (0.57) CLK1FYNAURKARPS6KB1VNN1
SCHEMBL4140030 0.83 FYN (0.53) CLK1FYNAURKARPS6KB1VNN1
SCHEMBL4191971 0.83 HDAC1 (0.47) CLK1FYNBRAFHDAC1
SCHEMBL4200498 0.83 FYN (0.64) S1PR1CLK1FYNRPS6KB1DYRK1A
SCHEMBL4190030 0.82 FYN (0.60) CLK1FYNAURKARPS6KB1VNN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163515-A1 Compounds Which Bind to the Active Site of Protein Kinase Enzymes BIOFOCUS DISCOVERY LTD. 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163515-A1 Compounds Which Bind to the Active Site of Protein Kinase Enzymes ROCK1, ROCK2, CIT S1PR1 946/4885CLK1 567/4885FYN 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.